Literature DB >> 19902106

Studying the association of polymorphic variants of GSTM1 and GSTT1 genes with breast cancer in female residents of Altai Krai.

N A Kostrykina1, E V Pechkovskii, O V Mishukova, U I Khripko, N A Zarubina, I A Selezneva, T V Sinkina, S A Terekhova, A F Lazarev, V D Petrova, M L Filipenko.   

Abstract

The incidence of homozygote deletion of glutathione S-transferase genes M1 and T1 (null genotypes; or GSTM1"-" and GSTT1"-") was studied in breast cancer patients living in Altai Krai. DNA was isolated from blood samples of 695 breast cancer patients (291 patients with familial cancer and 404 patients with sporadic cancer) and 263 women without history of tumor diseases. The frequency of GSTM1"-" and GSTT1"-" genotypes was estimated in breast cancer patients (47.2 and 19.1%, respectively) and non-cancer participants (46.8 and 19.0%, respectively). No differences were found in the frequency of genotypes. The frequency of genotype combination GSTM1"-"+GSTT1"-" in patients with sporadic breast cancer (11.6%, 47 of 404 patients) was higher than in the control (6.1%, 16 of 263 patients; OR=2.03; 95% CI=2.09-3.83; p=0.02). The genotype frequency of genes in the control group did not differ from that in European residents of the Caucasian race.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19902106     DOI: 10.1007/s10517-009-0649-1

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  2 in total

1.  Combined effects of GSTM1 and GSTT1 polymorphisms on breast cancer risk: A MOOSE-compliant meta-analysis and false-positive report probabilities test.

Authors:  Li-Feng Miao; Xiao-Yan Wang; Xiang-Hua Ye; Meng-Shen Cui; Xiao-Feng He
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

Review 2.  Possible Susceptibility Genes for Intervention against Chemotherapy-Induced Cardiotoxicity.

Authors:  Xinyu Yang; Guoping Li; Tao Yang; Manke Guan; Na An; Fan Yang; Qianqian Dai; Changming Zhong; Changyong Luo; Yonghong Gao; Saumya Das; Yanwei Xing; Hongcai Shang
Journal:  Oxid Med Cell Longev       Date:  2020-10-13       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.